TELA Bio, Inc. (TELA) Earnings Call Transcript & Summary

June 2, 2021

NASDAQ US Health Care Health Care Equipment and Supplies shareholder_meeting 7 min

Earnings Call Speaker Segments

Operator

operator
#1

Greetings. Welcome to the 2021 Annual Meeting of Stockholders of TELA Bio, Inc. [Operator Instructions]. If you would like to ask a question during the presentation, please click on the ask a question box on the left side of your screen, typing your question and hit submit. Please note, this conference is being recorded. I will now turn the conference over to your host, Doug Evans, Chairman of the Board of Directors of TELA Bio. Doug, please go ahead.

Douglas Evans

executive
#2

Thank you. Hello, ladies and gentlemen, I'd like to officially call the meeting to order, and welcome all of you to the 2021 Annual Meeting of Stockholders of TELA Bio, Inc. I'm Doug Evans, Director and Chairman of the Board of Directors of the company, and I'll be presiding at this meeting. This year, we're holding our annual meeting in all-virtual format, striving to make the meeting as accessible as possible by offering our stockholders the same opportunities to participate as would be available in an in-person meeting. We appreciate your participation today. Before proceeding to the business of the meeting, I'd like to introduce our Directors and members of our management team. In addition to myself, the following members of the Board of Directors are present today. Kurt Azarbarzin; Lisa Colleran; Antony Koblish; Federica O'Brien, Chair of the Audit Committee; and Adele Oliva, Chair of the Nominating and Corporate Governance Committee. Further, following executive officers of the company are also present. Antony Koblish, President and Chief Executive Officer; Nora Brennan, Chief Financial Officer; Skott Greenhalgh, Chief Technology Officer; and Pete Murphy, Chief Commercial Officer. We will conduct the business of our annual meeting first. And upon adjournment, members of the management will be available to answer questions. Also present today is Tom Klockner from KPMG LLP, the company's independent registered public accounting firm. During the question-and-answer period at the end of the meeting, he will be available to answer questions concerning the company's financial statements. In accordance with the company's second amended and restated bylaws and the direction of the Board, I hereby appoint Nora Brennan to serve as the independent inspector of election of this annual meeting. The agenda for the meeting and the list of rules of conduct for the meeting are available online through the virtual meeting portal. To conduct an orderly meeting, we ask that you abide by these rules. As stated in the rules of conduct, stockholders who desire to ask a question or speak during the meeting must do so through the online portal. When you use the ask a question button on the virtual meeting portal, please identify yourself, your status as a stockholder or representative of a stockholder. And state your point or ask your question. As stated in the rules of conduct, we ask that you restrict your questions to the items on the agenda that is before us today. Thank you for your cooperation with these rules. This meeting is held pursuant to a notice of Annual Meeting of Stockholders furnished to our stockholders on or about April 22, 2021. All stockholders of record at the close of business on April 15, 2021, are entitled to vote at the annual meeting. A list of holders of common stock entitled to vote at this meeting is available online through the virtual meeting portal. You may vote online by using the Vote My Shares button on the left side of the virtual meeting platform. Please choose that all votes submitted electronically must be received by the close of polls at the end of the meeting. All documents concerning the annual meeting, along with notice of this meeting are available through the virtual portal and will be filed with the records of the meeting. The inspector of election has examined the proxies received and reports that holders of a majority in voting power of all outstanding shares of common stock entitled to vote at the meeting are present or represented by proxy. Therefore, I declare a quorum present. On behalf of the Board of Directors, I'd like to express my appreciation to all stockholders who returned their proxies. And April 15, 2021 was fixed by the Board of Directors as the record date for the purpose of determining the stockholders entitled to vote at this meeting today. Only stockholders whose names appeared on the certified list of stockholders as of that date are entitled to vote at the meeting. According to the certified list of stockholders that are outstanding, 14,440,536 shares of common stock, and each stockholder is entitled to 1 vote per share. The first matter to be acted upon by the stockholders in proposal one, election of Class II Directors, each to serve a 3-year term until 2024 annual meeting of stockholders and until their successors, if any, are elected or appointed or their earlier death, resignation, retirement, disqualification or removal. The Board has nominated Kurt Azarbarzin and Antony Koblish to serve as Class II Directors. Proposal 2 is for the ratification of the selection of KPMG LLP as the company's independent registered public accounting firm for the 2021 fiscal year. The online voting system will remain open for another 5 minutes. If you previously voted by proxy, you do not need to vote today unless you would like to change your vote. [Voting]

Douglas Evans

executive
#3

We now have all the votes and proxies. I hereby declare the polls closed. The inspector of election will count the votes. A preliminary report of the inspector of elections reflects that a plurality of the eligible votes cast have been voted for election of each nominee for Class II Director and a majority of the eligible votes cast have been voted for the ratification of selection of KPMG LLP as the company's independent registered public accounting firm for the 2021 fiscal year. Thank you for your support. We will report the final results of this meeting in an upcoming current report on Form 8-K. I want to thank you all for attending today's meeting. The meeting is adjourned. We'll now have a brief question-and-answer period. It looks like there are no relevant questions that have been submitted, and I'd like to thank everyone for joining us today at TELA Bio's 2021 Annual Meeting of Stockholders. Enjoy the rest of your day.

Operator

operator
#4

This concludes today's conference, and you may disconnect at this time. Thank you for your participation.

For developers and AI pipelines

Programmatic access to TELA Bio, Inc. earnings transcripts and 32,000+ others is available through the EarningsCalls.dev REST API. Plans from $24.99/month — full transcripts, speaker segments, full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.